Ozelle unveils O-Cyte 1 with built-in cell imaging at MEDICA 2026

Ozelle is showcasing O-Cyte 1, an automated hematology analyzer that adds high-resolution cell imaging and AI-assisted morphology analysis to routine complete blood count testing. The company presented the system at MEDICA 2026 in Düsseldorf on November 16.
- O-Cyte 1 combines routine CBC testing with high-resolution cell imaging.
- Its AI × CBM technology supports AI-assisted morphology analysis.
- The analyzer differentiates white blood cells across seven categories.
- One unit processes up to 60 tests per hour, while six connected units reach up to 360.
- Live demonstrations continue through November 19 at MEDICA 2026.
Cell images alongside CBC results
O-Cyte 1 uses Ozelle's AI × CBM, or Complete Blood Morphology, technology to combine cell imaging with AI-assisted morphological analysis. The analyzer also provides white blood cell differentiation across seven categories.
Cell images captured during automated testing are made available with complete blood count results. According to Ozelle, laboratory professionals can review those images when an additional morphological assessment is needed, such as when a blood count produces an unusual finding.
The design is aimed at bringing cellular information into routine laboratory workflows rather than requiring a separate process. Ozelle co-founder and head of research and development Jie Du said the company wanted to integrate cellular morphology into routine CBC testing while maintaining laboratory workflow efficiency.
Automation for higher-volume laboratories
O-Cyte 1 supports batch loading of 25 sample tubes, automatic barcode-based sample identification and automatic sample mixing. It can draw samples from closed tubes and prioritize urgent STAT samples.
A standalone analyzer processes up to 60 tests per hour, while six connected units can reach up to 360 tests per hour. Ozelle says this configuration allows laboratories to expand capacity as workloads increase.
The system also addresses routine maintenance. Key fluid-contact components are integrated into a replaceable reagent kit, which the company says can help reduce cleaning inside the instrument. Built-in self-check functions and replaceable modules are intended to support troubleshooting and maintenance, as well as after-sales service by distributors.
Part of a wider diagnostic portfolio
Ozelle is also presenting its compact EHBT analyzer series for human medicine. The portfolio covers hematology, cell imaging, immunoassays and dry biochemistry, with an emphasis on reliable performance, simple operation and minimal routine maintenance.
The company's EHVT veterinary series offers hematology, digital cell morphology, immunoassays, biochemistry, and urine and feces analysis. Ozelle positions both product lines for clinics and decentralized diagnostic centers that need a broader range of tests in limited space and with fewer maintenance requirements.
Live demonstrations are scheduled to continue through November 19 at booth D63 in Hall 1 of Messe Düsseldorf. Visitors can see the analyzers operating and learn about their clinical applications and distribution opportunities. The announcement does not provide a launch date or commercial availability details for O-Cyte 1.


